Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss CRVS - Corvus Pharmaceuticals, Inc.
-967 K
LAST VALUE
-23.18%
2 YEAR CAGR
-95.34%
5 YEAR CAGR
0.00%
10 YEAR CAGR